Kolexia
Blay Jean Yves Oncologie médicale
Blay Jean Yves
Oncologie médicale
Centre Léon-Bérard
Lyon, France
1.4 K Activités
4.4 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Tumeurs stromales gastro-intestinales Tumeurs des tissus mous Récidive tumorale locale Métastase tumorale Léiomyosarcome Liposarcome Tumeurs osseuses Tumeurs du sein

Collaborateurs

Voir plus
Le Cesne Axel
Le Cesne Axel
Gustave-Roussy, Villejuif, France
Italiano Antoine
Italiano Antoine
Institut Bergonié, Bordeaux, France
Penel Nicolas
Penel Nicolas
Centre Oscar-Lambret, Lille, France
Ray Isabelle
Ray Isabelle
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
Edimark
16 collaboration(s)
Dernière en 2023
MSD
14 collaboration(s)
Dernière en 2023
Roche
10 collaboration(s)
Dernière en 2023
BMS
7 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
PREDOSTAR: A Multicenter, Open-label, Randomized Phase II Study Aiming to Assess the Clinical Impact of Dostarlimab on Occurrence of Second Primary Cancer in Patients With Cured Primary Cancer
Essai Clinique (GSK)   15 mars 2024
Guiding principles on the education and practice of theranostics.
European journal of nuclear medicine and molecular imaging   08 mars 2024
MULTISARC: Molecular Profiling of Advanced Soft-tissue Sarcomas. A Phase III Study
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   05 mars 2024
CAMPFIRE: Children's and Young Adult Master Protocol for Innovative Pediatric Research
Essai Clinique (Lilly)   04 mars 2024
Impact of artificial intelligence in transforming the doctor–cancer patient relationship
ESMO Real World Data and Digital Oncology   01 mars 2024
PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
AcSé: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
Essai Clinique (Unicancer)   26 février 2024
ChonDRAgon: A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma
Essai Clinique (Inhibrx, Inc.)   20 février 2024
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers.
NPJ precision oncology   16 février 2024
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN.
The Lancet regional health. Europe   16 février 2024